Hypoxenum capsules 0,25 g 30 pcs

Gipoksen® belongs to a class antihypoxants and antioxidants that reduce oxygen consumption and increase the efficiency of the body in extreme situations.

The drug has anti-hypoxic action by improving the efficiency of tissue respiration in hypoxia, especially in organs with high levels of metabolism (brain, heart muscle, liver).

Gipoksen® reduces oxygen consumption with considerable physical stress, improved tissue respiration, reduction of mental and physical fatigue, successful execution of physical labor intensive operations.

Active substance:
Polydihydroxyphenylenethiosulfonate sodium

Manufacturer

Olifen Corp., Russia

Composition

Active substance:

sodium polidigidroksifenilentiosulfonat (gipoksen®) 250 mg;

Material capsule: gelatin, black iron oxide (E 172), iron oxide red (E 172), iron oxide yellow (E 172), titanium dioxide (E 171)
.

Indications

• to enhance the efficiency and in extreme adverse conditions involving oxygen deficiency (including high altitude, Arctic conditions, subsea work);
• mental and physical stress, operator activities, and other heavy loads, accompanied by chronic fatigue and fatigue;
• in the treatment of severe traumatic injuries, blood loss, major surgery, respiratory diseases (asthma, pneumonia, obstructive bronchitis);
• in the complex treatment of stable angina pectoris (prevention of angina attacks), hypertension, chronic heart failure I and II NYHA functional class classification.

Contraindications

• increased sensitivity to the drug.


• hemorrhagic stroke;
• pregnancy;
• lactation;

Side effects

Perhaps: allergic reactions.

How to accept, acceptance rate and dosage

Inside, before or during meal time, with a little water. The single dose for adults – 2-4 capsules.

The maximum applied daily dose – 12 cps.

Removal of hypoxia developing in extreme conditions (hypoventilation, highlands, underwater works, the work in the conditions of elevated temperature, exercise), 1 daily dose for 30-60 min before loading.

Prolonged strenuous mental activity, chronic fatigue, reducing the recovery period after an excessive physical exertion, trauma, surgical interventions: 1/2 daily dose 2 times a day for 2-3 weeks. Courses can be repeated with a break for 1-2 weeks.

Comprehensive treatment of pneumonia: 1/2 daily dose 2 times a day, the course – 14 days.

A comprehensive treatment of obstructive bronchitis: 1/2 daily dose 2 times a day – 2 courses for 14 days with an interval of 7 days.

The complex treatment of bronchial asthma: 1/2 daily dose 2 times a day; Course – 21-30 days with 10 days interval.

Comprehensive prevention of stable angina : 1/2 daily dose 2 times a day, the course – 15-30 days with 10 days interval.

Comprehensive treatment of essential hypertension: 1/2 daily dose 2 times a day, the course – 10 days.

Comprehensive treatment of heart failure: 1/2 daily dose 2 times a day, the course – 10-14 days.

Storage conditions

In the dark place at a temperature not higher than 25 ° C

Active substance

Polydihydroxyphenylenethiosulfonate sodium

Interaction

Negatives pharmaceutical, pharmacodynamic and pharmacokinetic interactions with other drugs is not established.

Drug incompatibility with other drugs is not revealed.

Pregnancy and lactation

Do not use this drug during pregnancy and lactation.

Overdose

Symptoms : dry mouth, nausea and discomfort in the abdomen, in rare cases – respiratory depression.

Treatment : gastric lavage, administration of activated charcoal, symptomatic therapy.